Oregon Public Employees Retirement Fund’s Acadia Pharmaceuticals ACAD Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$728K	Buy	28,785 +200	+0.7%	+$4.4K	0.01%	1086
2026 Q1	$636K	Sell	28,585 -81	-0.3%	-$1.94K	0.01%	1085
2025 Q4	$766K	Buy	28,666 +566	+2%	+$13.5K	0.01%	982
2025 Q3	$600K	Sell	28,100 -100	-0.4%	-$2.37K	0.01%	1072
2025 Q2	$608K	Hold	28,200	–	–	0.01%	1038
2025 Q1	$468K	Buy	+28,200	New	+$512K	0.01%	1131

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Oregon Public Employees Retirement Fund's ACAD Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Acadia Pharmaceuticals (ACAD) stake by 0.7% in Q2 2026, buying an estimated $4.4K and bringing the position to 28,785 shares worth $728K. The position accounts for 0.01% of the portfolio, ranked #1086.

Oregon Public Employees Retirement Fund first reported a position in ACAD in Q1 2025 and has held it in 6 quarters since. The position peaked at $766K in Q4 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Oregon Public Employees Retirement Fund held 28,785 shares of Acadia Pharmaceuticals worth $728K as of Q2 2026.
Oregon Public Employees Retirement Fund bought 200 Acadia Pharmaceuticals shares in Q2 2026, an estimated $4.4K.
Acadia Pharmaceuticals made up 0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1086 holding.
Oregon Public Employees Retirement Fund first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Oregon Public Employees Retirement Fund's Acadia Pharmaceuticals position peaked at $766K in Q4 2025.
354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.